Dr. Baylis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
U of VA Sch of Med
Charlottesville, VA 22901
Education & Training
University of Virginia School of MedicineClass of 2017
Certifications & Licensure
CA State Medical License 2023 - 2025
MA State Medical License 2021 - 2023
Publications & Presentations
PubMed
- 139 citationsEffector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunityJ. David Peske, Elizabeth D. Thompson, Lelisa Gemta, Richard A. Baylis, Yang Xin Fu
Nature Communications. 2015-05-13 - 182 citationsStem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis.Gabriel F. Alencar, Katherine Owsiany, Santosh Karnewar, Katyayani Sukhavasi, Giuseppe Mocci
Circulation. 2020-11-24 - 53 citationsThe CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.Richard A. Baylis, Delphine Gomez, Ziad Mallat, Gerard Pasterkamp, Gary K. Owens
Arteriosclerosis, Thrombosis, and Vascular Biology. 2017-09-28
Journal Articles
- Interleukin-1β Has Atheroprotective Effects in Advanced Atherosclerotic Lesions of MiceRichard Baylis, MD, Nature
Press Mentions
- Discovery Reveals Potential Way to Prevent Heart Attacks, StrokesMarch 24th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
